Provided by Tiger Trade Technology Pte. Ltd.

HUA MEDICINE-B

3.420
+0.3109.97%
Volume:12.52M
Turnover:43.34M
Market Cap:3.61B
PE:-13.42
High:3.620
Open:3.130
Low:3.130
Close:3.110
52wk High:4.950
52wk Low:1.730
Shares:1.06B
HK Float Shares:1.06B
Volume Ratio:4.14
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.255
ROE:254.05%
ROA:-6.04%
PB:3.17
PE(LYR):-13.42
PS:6.48

Loading ...

Hua Medicine Wins Hong Kong Approval for Dorzagliatin Type 2 Diabetes Treatment

Reuters
·
Mar 03

Hua Medicine - Approval of Dorzagliatin for Marketing in China

THOMSON REUTERS
·
Mar 03

Hua Medicine (02552) Releases Monthly Return on Movements in Securities for January 2026

Bulletin Express
·
Feb 05

Hua Medicine (Shanghai) Ltd.'s (HKG:2552) stock price dropped 13% last week; individual investors would not be happy

Simply Wall St.
·
Feb 03

HUA MEDICINE-B (02552) Rises Over 3% as Second-Gen GKA Completes First Dosing in U.S. MAD Ib Trial, Eyes Future Partnerships

Stock News
·
Dec 10, 2025

HUA MEDICINE-B (02552): First Patient Successfully Dosed in U.S. MAD Ib Trial for Second-Generation GKA HMS1005

Stock News
·
Dec 09, 2025

Hua Medicine Doses First Patient in US Phase Ib Trial of HMS1005 for Type 2 Diabetes

Reuters
·
Dec 09, 2025

Hua Medicine (02552) Releases November 2025 Monthly Return, No Change in Issued Shares

Bulletin Express
·
Dec 04, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

HK Stock Movement | HUA MEDICINE-B (02552) Rises Over 4% in Late Trading as Second-Generation GKA Submits Clinical Application to FDA, Leading Industry R&D

Stock News
·
Dec 01, 2025

HUA MEDICINE-B (02552) Grants 20 Million Share Options in Total

Stock News
·
Dec 01, 2025

Hua Medicine (2552) Announces Grant of 20,000,000 Share Options

Bulletin Express
·
Dec 01, 2025

Hua Medicine (2552) Announces Change in Remuneration Committee

Bulletin Express
·
Nov 27, 2025

Hua Medicine Files Directors List to HKEX

Reuters
·
Nov 27, 2025

HUA MEDICINE-B (02552): Zhang Yaoliang Appointed as Member of Remuneration Committee

Stock News
·
Nov 27, 2025

Hua Medicine Appoints Andy Cheung to Remuneration Committee

Reuters
·
Nov 27, 2025

Guosheng Securities Initiates Coverage on HUA MEDICINE-B (02552) with "Buy" Rating, Citing Leadership in Global GKA Diabetes Treatment

Stock News
·
Nov 24, 2025

Hua Medicine (02552) Releases Monthly Return as of 31 October 2025

Bulletin Express
·
Nov 06, 2025